MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,056,912 | +2.8% | 195,320 | +5.7% | 0.04% | -2.4% |
| Q1 2023 | $6,867,741 | +260.7% | 184,716 | +339.6% | 0.04% | +223.1% |
| Q4 2022 | $1,904,017 | +847.3% | 42,022 | +4497.6% | 0.01% | +550.0% |
| Q4 2020 | $201,000 | -82.7% | 914 | -96.1% | 0.00% | -88.9% |
| Q2 2018 | $1,159,000 | +60.7% | 23,500 | 0.0% | 0.02% | +50.0% |
| Q1 2018 | $721,000 | +38.7% | 23,500 | -17.5% | 0.01% | +33.3% |
| Q4 2017 | $520,000 | +89.1% | 28,500 | +21.3% | 0.01% | +80.0% |
| Q3 2017 | $275,000 | +570.7% | 23,500 | +109.8% | 0.01% | +400.0% |
| Q2 2017 | $41,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |